Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ankur Poddar"'
Autor:
Ankur Poddar, Raina Chhajer
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Workplace mental health challenges have emerged as a significant concern post-pandemic. Despite this, the pervasive stigma surrounding mental illness leads to the concealment of symptoms and reluctance to seek professional help among employe
Externí odkaz:
https://doaj.org/article/eb453ecbb4ab42c192f05b105ea8ddf3
Autor:
Rahul Shukla, Ravi Kant Rajpoot, Ankur Poddar, Richa Ahuja, Hemalatha Beesetti, Rajgokul K. Shanmugam, Shivam Chaturvedi, Kaushal Nayyar, Deepika Singh, Venugopal Singamaneni, Prasoon Gupta, Ajai Prakash Gupta, Sumeet Gairola, Pankaj Kumar, Y. S. Bedi, Tapesh Jain, Bhupendra Vashishta, Ravindra Patil, Harish Madan, Sumit Madan, Rinku Kalra, Ruchi Sood, Ram A. Vishwakarma, D. Srinivasa Reddy, Altaf A. Lal, Upasana Arora, Navin Khanna
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Dengue is a serious public health concern worldwide, with ∼3 billion people at risk of contracting dengue virus (DENV) infections, with some suffering severe consequences of disease and leading to death. Currently, there is no broad use vaccine or
Externí odkaz:
https://doaj.org/article/a2f36b9d0b3b4046aab203f00ae8f603
Autor:
Rahul Shukla, Viswanathan Ramasamy, Ravi Kant Rajpoot, Upasana Arora, Ankur Poddar, Richa Ahuja, Hemalatha Beesetti, Sathyamangalam Swaminathan, Navin Khanna
Publikováno v:
Expert Review of Vaccines, Vol 18, Iss 2, Pp 105-117 (2019)
Introduction: A safe and efficacious vaccine for dengue continues to be an unmet public health need. The recent licensing of a dengue vaccine (Dengvaxia) developed by Sanofi has brought to the fore the safety issue of vaccine-induced infection enhanc
Externí odkaz:
https://doaj.org/article/b75431d483eb4380b33f0cb62dcf1e4e
Autor:
Rahul Shukla, Hemalatha Beesetti, Julia A. Brown, Richa Ahuja, Viswanathan Ramasamy, Rajgokul K. Shanmugam, Ankur Poddar, Gaurav Batra, Florian Krammer, Jean K. Lim, Sachin Kale, Altaf A. Lal, Sathyamangalam Swaminathan, Navin Khanna
Publikováno v:
EBioMedicine, Vol 60, Iss , Pp 102991- (2020)
Background: A tetravalent live attenuated dengue vaccine, Dengvaxia, sensitised naïve recipients to severe dengue illness upon a subsequent natural dengue infection and is suspected to be due to antibody-dependent enhancement (ADE). ADE has also bee
Externí odkaz:
https://doaj.org/article/58d16850c9d34227bb00e1774b315ae7
Autor:
Rahul Shukla, Ravi K. Rajpoot, Upasana Arora, Ankur Poddar, Sathyamangalam Swaminathan, Navin Khanna
Publikováno v:
Frontiers in Microbiology, Vol 8 (2018)
Dengue, a significant public health problem in several countries around the world, is caused by four different serotypes of mosquito-borne dengue viruses (DENV-1, -2, -3, and -4). Antibodies to any one DENV serotype which can protect against homotypi
Externí odkaz:
https://doaj.org/article/2ebc1bd7941442faaf290cbf5fe67a08
Autor:
Viswanathan Ramasamy, Upasana Arora, Rahul Shukla, Ankur Poddar, Rajgokul K Shanmugam, Laura J White, Melissa M Mattocks, Rajendra Raut, Ashiya Perween, Poornima Tyagi, Aravinda M de Silva, Siddhartha K Bhaumik, Murali Krishna Kaja, François Villinger, Rafi Ahmed, Robert E Johnston, Sathyamangalam Swaminathan, Navin Khanna
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 12, Iss 1, p e0006191 (2018)
Dengue is one of the fastest spreading vector-borne diseases, caused by four antigenically distinct dengue viruses (DENVs). Antibodies against DENVs are responsible for both protection as well as pathogenesis. A vaccine that is safe for and efficacio
Externí odkaz:
https://doaj.org/article/1493e4510e824e5a9dcf9fc2b8abf687
Autor:
Tapas Bandyopadhyay, Sabbir Ahmed, Samiul Akhtar, Madhusha Mukhopadhyay, Ankur Poddar, Rohitaswa Mandal, Amitabha Saha
Publikováno v:
Bengal Physician Journal. 8:52-56
Publikováno v:
Endocrine Abstracts.
Autor:
Rinku Kalra, Ravi Kant Rajpoot, Rajgokul K. Shanmugam, Richa Ahuja, Hemalatha Beesetti, Harish Kumar Madan, Navin Khanna, Ankur Poddar, Bhupendra Vashishta, D. Srinivasa Reddy, Rahul Shukla, Ram A. Vishwakarma, Prasoon Gupta, Kaushal Nayyar, Yashbir S. Bedi, Tapesh Jain, Venugopal Singamaneni, Ajai Prakash Gupta, Shivam Chaturvedi, Sumeet Gairola, Ravindra Patil, Pankaj Kumar, Deepika Singh, Ruchi Sood, Sumit Madan, Altaf A. Lal, Upasana Arora
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Frontiers in Microbiology
Frontiers in Microbiology
Dengue is a serious public health concern worldwide, with ∼3 billion people at risk of contracting dengue virus (DENV) infections, with some suffering severe consequences of disease and leading to death. Currently, there is no broad use vaccine or
Autor:
Navin Khanna, Ravi Kant Rajpoot, Sathyamangalam Swaminathan, Viswanathan Ramasamy, Rahul Shukla, Upasana Arora, Richa Ahuja, Ankur Poddar, Hemalatha Beesetti
Publikováno v:
Expert Review of Vaccines. 18:105-117
Introduction: A safe and efficacious vaccine for dengue continues to be an unmet public health need. The recent licensing of a dengue vaccine (Dengvaxia) developed by Sanofi has brought to the fore the safety issue of vaccine-induced infection enhanc